References in periodicals archive ?
Smiths Detection's latest innovation, HI-SCAN 6040 CTiX, has been developed to enhance airport checkpoint screening measures and processes.
The CTiX is Smiths Detection's latest innovation and has been designed to enhance airport screening; efficiency; and passenger experience at the checkpoint.
The newly launched HI-SCAN 6040 CTiX eliminates the need to remove electronic devices and liquids from hand luggage, subject to approval from the appropriate local authorities.
Headquartered in Beverly, Massachusetts, Cellceutix is a publicly traded company under the symbol "CTIX".
The Hi-Scan 6040 CTiX scanner, which is the first to feature the company's proprietary CT scanning technology, can be incorporated easily into existing checkpoint lanes at minimal upgrade costs.
M2 EQUITYBITES-October 10, 2017-Smiths Detection HI-SCAN 6040 CTiX scanner enhances security and operational efficiency
With one dual-view and two multi-view X-ray scanner models achieving EDS CB standards, coupled with the development of our HI-SCAN 6040 CTiX system targeting C3 approval, we can now offer a full range of checkpoint systems that meet the new EU regulations, commented Cameron Mann, Global Market Director for Aviation at Smiths Detection.
Only Cheap Tickets (CTIX) held up, almost unchanged, as the buyout from Cendant stayed in place at the original price of $16.50 per share.
(KAL611) SAM GALEOTOS, CEO of CHEAP TICKETS INC (CTIX), describes the company's business and its background; prospects for the industry, with positive and negative trends; competitive threats; strategic opportunities for the firm including its marketing plans and acquisition potential; management strength and organization; and the financial prospects of the firm looking forward.
At inter airport Europe it will showcase its CT technology solutions, including the HI-SCAN 6040 CTiX explosive detection machine, a new cabin baggage screening system, and CORAL, a predictive analytic services suite.
United States-based Cellceutix (CTIX:OTC US) has submitted a special protocol assessment request, along with a final protocol for a phase three clinical trial of its Brilacidin to the US Food and Drug Administration, it was reported yesterday.
Classic Voyage OTC 2.15 1.36 -0.79 AQSE Aquasearch OTC 0.23 0.21 -0.02 BOH Pacific Century Financial NYSE 26.12 23.37 -2.75 BRN Barnwell Industires ASE 19.90 18.75 -1.15 BWE BancWest NYSE 34.91 34.93 0.02 CTIX Cheap Tickets OTC 16.40 16.39 -0.01 CBBI CB Bancshares OTC 38.00 34.60 -3.40 CEAT CEATECH USA OTC 1.00 0.55 -0.45 CPBI CPB, Inc.
Acronyms browser ?
Full browser ?
- CTL differentiation factor